We are live on ! Find out more
ADXN

Addex Therapeutics
ADXN

5 hedge funds and large institutions have $106K invested in Addex Therapeutics in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

680% more capital invested

Capital invested by funds: $13.6K → $106K (+$92.2K)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

67% more funds holding

Funds holding: 3 → 5 (+2)

1.28% more ownership

Funds ownership: 0.13% → 1.41% (+1.3%)

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$110K
2
Morgan Stanley
Morgan Stanley
New York
+$14.1K
3
GI
GAMMA Investing
California
+$9.21K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$656

Top Sellers

Rank Fund Capital Flow
1
ACM
ADAR1 Capital Management
Texas
-$9.77K

ADXN Hedge Fund Activity: Q4 2024 in Review

5 of the 7,609 institutional investors tracked by Wall St. Rank reported a position in Addex Therapeutics (ADXN) for Q4 2024, worth a combined $106K — up 680% from $13.6K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ADXN positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $110K. The largest seller was ADAR1 Capital Management, exiting entirely with an estimated $9.77K sold.

  • 5 institutional investors held Addex Therapeutics (ADXN) as of Q4 2024, up from 3 in Q3 2024.
  • Funds reported $106K of Addex Therapeutics stock for Q4 2024, up 680% quarter-over-quarter.
  • 3 funds opened new Addex Therapeutics positions in Q4 2024 and 1 closed out, a net change of +2 holders.
  • The largest Addex Therapeutics buyer in Q4 2024 was Citadel Advisors, an estimated $110K added.
  • The largest Addex Therapeutics seller in Q4 2024 was ADAR1 Capital Management, an estimated $9.77K sold.

Based on aggregated 13F filings for Q4 2024.